Precision cancer medicine 2025: some concerns.
作者信息
Nygren Peter
机构信息
Department of Immunology, Genetics and Pathology, Rudbecklaboratoriet, Uppsala University, Uppsala, Sweden.
出版信息
Acta Oncol. 2025 Sep 11;64:1202-1204. doi: 10.2340/1651-226X.2025.44604.
Abstract
摘要
相似文献
1
Precision cancer medicine 2025: some concerns.2025年精准癌症医学：一些担忧。
Acta Oncol. 2025 Sep 11;64:1202-1204. doi: 10.2340/1651-226X.2025.44604.
2
Unveiling the Disparities in the Field of Precision Medicine: A Perspective.揭示精准医学领域的差异：一种观点。
Health Sci Rep. 2025 Jul 27;8(8):e71102. doi: 10.1002/hsr2.71102. eCollection 2025 Aug.
3
Healthcare professionals' attitudes toward cancer precision medicine: A systematic review.医疗保健专业人员对癌症精准医学的态度：系统评价。
Semin Oncol. 2019 Jun;46(3):291-303. doi: 10.1053/j.seminoncol.2019.05.001. Epub 2019 Jun 10.
4
Exploring doctors' perspectives on precision medicine and AI in colorectal cancer: opportunities and challenges for the doctor-patient relationship.探索医生对结直肠癌精准医学和人工智能的看法：医患关系面临的机遇与挑战
BMC Med Inform Decis Mak. 2025 Jul 30;25(1):283. doi: 10.1186/s12911-025-03134-0.
5
Patient views on genetics and functional imaging for precision medicine: a willingness-to-pay analysis.
Per Med. 2022 Mar;19(2):103-112. doi: 10.2217/pme-2021-0067. Epub 2022 Jan 5.
6
Challenges in Implementing Comprehensive Precision Medicine Screening for Ovarian Cancer.实施卵巢癌综合精准医学筛查面临的挑战。
Curr Oncol. 2024 Dec 18;31(12):8023-8038. doi: 10.3390/curroncol31120592.
7
Understanding men's beliefs and concerns about linking health data in the context of precision medicine.了解男性在精准医疗背景下对关联健康数据的信念和担忧。
J Clin Transl Sci. 2023 Jun 7;7(1):e150. doi: 10.1017/cts.2023.573. eCollection 2023.
8
Big Advocacy, Little Recognition: The Hidden Work of Black Patients in Precision Medicine.大力倡导，鲜被认可：精准医学中黑人患者的隐性工作
Res Sq. 2023 Mar 20:rs.3.rs-2340760. doi: 10.21203/rs.3.rs-2340760/v1.
9
Precision cancer medicine and the doctor-patient relationship: a systematic review and narrative synthesis.精准癌症医学与医患关系：系统评价和叙述性综合。
BMC Med Inform Decis Mak. 2023 Dec 14;23(1):286. doi: 10.1186/s12911-023-02395-x.
10
It provides families with other avenues for treatment when there are no other options Surgeons' perspectives of being part of a precision medicine trial for poor prognosis paediatric cancer patients: A short report.为预后不良的儿科癌症患者开展精准医学试验时，该项目为那些没有其他选择的家庭提供了其他治疗途径：一份简短报告。
Cancer Med. 2024 May;13(9):e7209. doi: 10.1002/cam4.7209.
本文引用的文献
1
The present and future of precision oncology and tumor-agnostic therapeutic approaches.精准肿瘤学与肿瘤非特异性治疗方法的现状与未来。
Oncologist. 2025 Jun 4;30(6). doi: 10.1093/oncolo/oyaf152.
2
Medical digital twins: enabling precision medicine and medical artificial intelligence.医学数字孪生：推动精准医学与医学人工智能发展
Lancet Digit Health. 2025 Jun 14:100864. doi: 10.1016/j.landig.2025.02.004.
3
Encorafenib, Cetuximab, and mFOLFOX6 in -Mutated Colorectal Cancer.恩考芬尼、西妥昔单抗和改良FOLFOX6方案用于KRAS基因突变型结直肠癌的治疗
N Engl J Med. 2025 Jun 26;392(24):2425-2437. doi: 10.1056/NEJMoa2501912. Epub 2025 May 30.
4
Accelerating precision oncology by converging pragmatic trials and real-world evidence.通过融合实用试验和真实世界证据加速精准肿瘤学发展
Nat Rev Drug Discov. 2025 Mar 13. doi: 10.1038/d41573-025-00047-5.
5
Hallmarks of artificial intelligence contributions to precision oncology.人工智能对精准肿瘤学贡献的标志。
Nat Cancer. 2025 Mar;6(3):417-431. doi: 10.1038/s43018-025-00917-2. Epub 2025 Mar 7.
6
Ethical and Clinical Considerations in Ordering and Responding to Molecular Diagnostics and Circulating Tumor DNA as the Science Evolves.随着科学的发展，在订购和回应分子诊断及循环肿瘤DNA方面的伦理与临床考量
JCO Oncol Pract. 2024 Nov;20(11):1508-1514. doi: 10.1200/OP-24-00481. Epub 2024 Nov 12.
7
The ESMO Tumour-Agnostic Classifier and Screener (ETAC-S): a tool for assessing tumour-agnostic potential of molecularly guided therapies and for steering drug development.ESMO 肿瘤不可知分类器和筛查器（ETAC-S）：一种用于评估基于分子靶向治疗的肿瘤不可知性和指导药物开发的工具。
Ann Oncol. 2024 Nov;35(11):936-953. doi: 10.1016/j.annonc.2024.07.730. Epub 2024 Aug 25.
8
PCM4EU and PRIME-ROSE: Collaboration for implementation of precision cancer medicine in Europe.PCM4EU 和 PRIME-ROSE：在欧洲实施精准肿瘤医学的合作。
Acta Oncol. 2024 May 23;63:385-391. doi: 10.2340/1651-226X.2024.34791.
9
Cancer biomarkers: Emerging trends and clinical implications for personalized treatment.癌症生物标志物：个性化治疗的新兴趋势和临床意义。
Cell. 2024 Mar 28;187(7):1617-1635. doi: 10.1016/j.cell.2024.02.041.
10
A federated learning system for precision oncology in Europe: DigiONE.欧洲用于精准肿瘤学的联邦学习系统：DigiONE。
Nat Med. 2024 Feb;30(2):334-337. doi: 10.1038/s41591-023-02715-8.
Zotero 插件